Commentary: The Federal Government Loses More Money than Could Ever Be Accounted For

Accountant working on spreadsheets

Not long after Jeremy Gober started running a sleep center, he quit treating patients for narcolepsy and sleep apnea and went full-time submitting bogus insurance claims. According to Gober’s 2022 indictment, he committed at least one especially sloppy error: One of his make-believe billings included a Medicare claim for treatment in March 2018 for a patient who’d died in December 2017. Before Gober was caught, Medicare and California’s healthcare system, Medi-Cal, ended up paying him a total of $587,000 for claims that turned out to be fiction.

The payments to Gober were part of $260 million the U.S. Department of Health and Human Services spent from 2009 through 2019 to reimburse healthcare providers in 15 states and Puerto Rico for services to patients who were dead, according to the inspector general of the HHS, which administers Medicare and Medicaid — programs with combined expenditures of $1.7 trillion.

Read More

Commentary: Rural and Hispanic Communities Among Those Most Benefited by Telehealth

Telehealth has become a health care gamechanger for tens of millions of Americans.

We all know the time and effort an in-person health visit takes – travel to the appointment, time off work, hours spent in an office, follow ups that require us to do the whole process over again. But telehealth expansion in the post-COVID world has changed everything.

Read More

Combined Social Security Trust Fund Projected to Deplete Reserves by 2035

Social Security

Two reports released Monday show that the U.S. combined Social Security trust fund is projected to deplete its reserves by 2035.

The Trustees for Social Security and Medicare released annual reports on Monday. The Trustees projected the Medicare Hospital Insurance trust fund will exhaust its reserves in 2036. The Social Security Old-Age and Survivors Insurance (OASI) trust fund was projected to be insolvent by 2033.

Read More

Watchdog: Biden’s 2025 Budget Would Drive National Debt to $45 Trillion in 10 Years, 106 Percent of GDP

The Committee for a Responsible Federal Budget (CRFB) a budget watchdog group, found that President Joe Biden’s fiscal year 2025 budget would drive the national debt to $45.1 trillion or 106 percent of the U.S. Gross Domestic Product (GDP) by 2034, from $27.4 trillion or about 97 percent of GDP at the present time.

The organization noted that those calculations are based on the Biden administration’s own internal figures. The current $27.4 trillion debt figure is the debt held by the public, not the total national debt including intragovernmental holdings.

Read More

Commentary: Congress Should Support Site-Neutral Reforms

The recent Health Equity Report by BlueCross BlueShield of Tennessee offers a glimpse into the health challenges faced by Tennesseans. Among many concerning statistics, one stands out: 100 people are diagnosed with cancer in the state every day.

Sadly, the financial toll of chronic illnesses like cancer is staggering. It can saddle seniors, families and patients across Tennessee with decades of debt. Nationwide, 23 million Americans are confronting the burdensome reality of medical debt, which can wreck credit scores, send seniors to debt collections, and thwart patients from getting the timely, quality care they need.

Read More

Big Pharma Raises Hundreds of Drug Prices Despite Biden Admin Efforts to Keep Costs Down

Pharmacist

Top pharmaceutical companies raised the list price on 775 brand-name drugs in just the first half of January, even as President Joe Biden aims to keep prices low, according to The Wall Street Journal.

The median price hike of the drugs was around 4.5%, with some rising by 10% or more, despite an inflation rate of 3.4% year-over-year in December, according to data from 46brooklyn Research acquired by the WSJ. The price hikes are in contrast to the president’s efforts to tame rising drug prices, taking actions such as imposing automatic rebates to Medicare for drugmakers that raise their prices faster than the price of inflation, which first went into effect in December, affecting 48 drugs covered under Medicare Part B.

Read More